Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Norketotifen in Healthy Subjects

NCT03712163 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

74

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: Norketotifen Oral Capsule (Cohort 1)
DRUG: Norketotifen Oral Capsule (Cohort 2)
DRUG: Norketotifen Oral Capsule (Cohort 3)
DRUG: Norketotifen Oral Capsule (Multiple Dose Cohort)
DRUG: Placebo Oral Capsule

Sponsor

Emergo Therapeutics, Inc.